OraSure Technologies Appoints Lelio Marmora to Board of Directors
BETHLEHEM, Pa., May 29, 2020 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic […]
Jura Energy Corporation Announces Update to Annual and Q1 Filings
CALGARY, Alberta, May 29, 2020 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) is providing an update on […]
Huize Holding Limited Reports First Quarter 2020 Unaudited Financial Results
SHENZHEN, China, May 29, 2020 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading […]
Bilibili Inc. Prices Offering of Convertible Senior Notes
SHANGHAI, China, May 29, 2020 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI), a leading online entertainment […]
Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
— First NDA filing of savolitinib globally —— Chi-Med seeking first-in-class Chinese marketing authorization for a selective MET inhibitor —LONDON, May 29, 2020 (GLOBE [...]
Tiziana Life Sciences announces presentation of StemPrintER, a superior prognostic test as compared to Oncotype DX to predict breast cancer
StemPrintER Outperforms Oncotype DX in analysis with 800+ samples from ER+/HER2- postmenopausal breast cancer patientsSPARE Model is up to 40-50% […]
ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020
Geneva, Switzerland and Boston, MA – May 29, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]
Qutoutiao Inc. to Report First Quarter 2020 Results on Thursday, June 4, 2020
SHANGHAI, China, May 28, 2020 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao” or the “Company”) (NASDAQ: QTT), a leading operator of […]
First Busey Corporation Announces Pricing of Subordinated Notes Offering
CHAMPAIGN, Ill., May 28, 2020 (GLOBE NEWSWIRE) — First Busey Corporation (NASDAQ: BUSE) (the “Company”), the holding company for Busey Bank […]
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $525 Million of Common Stock
SAN CARLOS, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a late-stage biotechnology company developing […]
